Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The stock of Abivax has risen by 2.37% to 99.20 euros in this Monday's session on February 9, 2026. This increase is part of a positive trend over a w…
The Abivax stock shows an increase of 1.92% at midday this Tuesday, February 3, 2026, reaching 95.50 euros. This progress follows a week marked by a 6…
Abivax shares fell 4.54% on Monday, February 2, 2026, at midday, trading at 90.50 euros compared to 94.80 euros last Friday. This correction occurs in…
Abivax, a specialist in chronic inflammatory diseases, closed the week of January 31, 2026, at 94.80 euros, marking a decline of 8.85% over five sessi…
Abivax shares increased by 2.77% on Tuesday, January 20, closing at 103.80 euros, amid fresh speculation about a potential merger and acquisition oper…
Stifel établit une recommandation d'achat sur Abivax et fixe un objectif de cours à 142 €.
Abivax climbs 4.63% by midday on Thursday, January 15, reaching 113 euros, supported by several upward revisions of target prices by analysts and ongo…
On Wednesday, January 14th, Abivax's stock price increased by 2.69% to 106.80 euros, driven by course target revisions and unconfirmed speculations ab…
French biotech company Abivax saw its shares soar by 27.07% Monday morning, crossing the threshold of 125.80 euros, while the CAC 40 index fell by 0.5…
Biotechnology company Abivax has outlined its priorities for 2026, focusing on completing its Phase 3 maintenance trial for obefazimod in treating ulc…
